TOP STORIES

• BUSINESS Sanofi Japan Introduces 2-Week-Rule before Getting Back to Full Operations after COVID-19 Emergency Lift
  May 29, 2020

• ACADEMIA Nagasaki Univ. to Launch Clinical Trial for Nelfinavir for COVID-19
  May 28, 2020

• BUSINESS Drug Makers Exploring “New Normal” in Post-COVID-19; Takeda Plans Major Changes
  May 28, 2020

• BUSINESS Japan SGLT2 Inhibitor Market Hits 100 Billion Yen after Weak Start: Jiho Estimate
  May 27, 2020

• REGULATORY Japan Drops May-End Goal for Avigan’s COVID-19 Approval
  May 27, 2020

• ACADEMIA Discontinued HIV Med Nelfinavir Hits Limelight as Potential COVID-19 Treatment
  May 26, 2020

• REGULATORY MSD’s 9-Valent HPV Vaccine Now in Line for June Approval; Eyes on Its Possible Inclusion in National Immunization Program
  May 25, 2020

• BUSINESS GSK Japan Looking to Develop Otilimab for COVID-19; President Stresses Efforts on Vaccines, Disease Management Too
  May 22, 2020

• ACADEMIA Avigan Interim Analysis Not Intended to Determine Efficacy, Research Sponsor Says on Reports
  May 21, 2020

• REGULATORY MHLW Adds Veklury in Updated COVID-19 Treatment Guide
  May 20, 2020

• BUSINESS Nichi-Iko Launches Another Recall, Now Pulling 8 More APIs/9 Products
  May 19, 2020

• REGULATORY Check Latest Info and Make Careful Decision on Veklury Use: PMDA Review Report
  May 19, 2020

• BUSINESS Many Drug Makers Continue Work-from-Home, Voluntary Visit Bans after Govt Partially Lifts COVID-19 Emergency
  May 18, 2020

• BUSINESS Takeda Revving Up Efforts to Retool Japan Sales System as It Prepares for “New Normal” Post COVID-19
  May 18, 2020

• REGULATORY Japan’s First Humira Biosimilar Could Hit Market as Early as November
  May 15, 2020

• REGULATORY Japan Poised to Quickly Approve Futhan, Actemra, Ivermectin for COVID-19 If Effective: Abe
  May 15, 2020

• REGULATORY Chuikyo Members Frown on Zolgensma’s Sakigake Premium; Topic Up for 2022 Pricing Debate
  May 14, 2020

• BUSINESS Eisai Resurrects Eritoran as Potential COVID-19 Treatment, Eyes Trial Launch Next Month
  May 14, 2020

• BUSINESS Takeda Exec Says Plasma Alliance Could Start Clinical Trial for Unbranded Therapy in July
  May 14, 2020

• REGULATORY Daiichi Sankyo’s Enhertu, Novartis’ Beovu, Novo’s Ozempic OK’ed for Listing on May 20
  May 13, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 113
• 114
• 115
• 116
• 117
• 118
• 119
• 120
• 121
• …
• Next ›
• 最終 »